Long-Term Outcomes of Teplizumab in Routine Clinical Care
IsraelRecruiting
Conditions
Type 1 Diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Investigational Site Number: 8400003, Atlanta, Georgia, United States
Investigative Site Number: 8400004, Atlanta, Georgia, United States
Investigative Site Number: 8400002, Syosset, New York, United States
Investigational Site Number: 8400005, Sandy City, Utah, United States
Investigative Site Number: 3760003, Petah Tikva, Israel
Investigative Site Number: 3760002, Ramat Gan, Israel
Investigational Site Number: 3760001, Ramat Gan, Israel
Investigative Site Number: 7840001, Abu Dhabi, United Arab Emirates